Sale!

DRD2 Gene Myoclonic Dystonia Genetic Test

Original price was: $700.Current price is: $500.

-29%

The DRD2 Gene Myoclonic Dystonia NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the DRD2 gene associated with myoclonic dystonia. This comprehensive test utilizes Next-Generation Sequencing (NGS) technology to provide accurate detection of genetic variants responsible for this neurological movement disorder. Patients experiencing involuntary muscle contractions, dystonic postures, or family history of movement disorders should consider this test. The test offers definitive diagnosis, enables personalized treatment planning, and provides crucial information for family genetic counseling. Available for only $500 USD, this advanced genetic testing helps neurologists and genetic specialists develop targeted therapeutic approaches for better patient outcomes.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

DRD2 Gene Myoclonic Dystonia NGS Genetic DNA Test

Comprehensive Genetic Testing for Movement Disorders

The DRD2 Gene Myoclonic Dystonia NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics, offering precise identification of genetic mutations responsible for myoclonic dystonia. This advanced testing methodology provides crucial insights for patients and healthcare providers dealing with complex movement disorders.

What is DRD2 Gene Myoclonic Dystonia?

Myoclonic dystonia, also known as hereditary myoclonus-dystonia syndrome, is a rare neurological movement disorder characterized by rapid, brief muscle contractions (myoclonus) combined with sustained muscle contractions causing abnormal postures (dystonia). The DRD2 gene plays a critical role in dopamine receptor function within the central nervous system, and mutations in this gene can disrupt normal neurological signaling pathways.

What the Test Measures and Detects

Our comprehensive NGS-based genetic test specifically targets:

  • Complete sequencing of the DRD2 gene to identify pathogenic variants
  • Detection of single nucleotide polymorphisms (SNPs) and copy number variations (CNVs)
  • Analysis of gene regions associated with dopamine receptor dysfunction
  • Identification of both inherited and de novo mutations

Advanced NGS Technology

Utilizing state-of-the-art Next-Generation Sequencing technology, this test provides:

  • High-resolution genetic mapping with 99.9% accuracy
  • Comprehensive coverage of all coding regions
  • Detection of rare and novel mutations
  • Simultaneous analysis of multiple genetic markers

Who Should Consider This Test?

This genetic test is recommended for individuals experiencing:

  • Involuntary muscle jerks or twitches (myoclonus)
  • Sustained muscle contractions causing abnormal postures
  • Family history of movement disorders or dystonia
  • Onset of symptoms in childhood or early adulthood
  • Neurological symptoms that worsen with stress or caffeine
  • Previous inconclusive neurological evaluations

Clinical Indications

Patients presenting with the following clinical features should consider testing:

  • Combined myoclonic and dystonic movements
  • Symptoms primarily affecting upper body and neck
  • Alcohol-responsive movement abnormalities
  • Progressive neurological symptoms without clear cause

Benefits of DRD2 Genetic Testing

Undergoing this comprehensive genetic analysis provides numerous advantages:

  • Definitive Diagnosis: Confirms or rules out genetic causes of movement disorders
  • Personalized Treatment: Enables targeted therapeutic approaches based on genetic profile
  • Family Planning: Provides crucial information for genetic counseling and family planning decisions
  • Prognostic Information: Helps predict disease progression and potential complications
  • Research Contribution: Contributes to ongoing neurological genetics research

Clinical Management Advantages

Genetic testing results directly impact clinical management by:

  • Guiding medication selection for optimal symptom control
  • Informing decisions about deep brain stimulation eligibility
  • Facilitating early intervention strategies
  • Reducing diagnostic uncertainty and unnecessary testing

Understanding Your Test Results

Our comprehensive genetic counseling support helps you interpret your results:

Positive Result

A positive result indicates the presence of a pathogenic DRD2 gene mutation. This confirms the genetic basis of your symptoms and enables:

  • Targeted treatment planning with your neurologist
  • Family member testing recommendations
  • Long-term management strategy development
  • Connection with specialized movement disorder centers

Negative Result

A negative result suggests that DRD2 mutations are not the cause of your symptoms, which helps:

  • Direct further diagnostic evaluation toward other potential causes
  • Prevent unnecessary treatments targeting DRD2-related pathways
  • Focus on alternative neurological conditions
  • Provide reassurance about genetic transmission risks

Variant of Uncertain Significance (VUS)

If a genetic variant of unknown clinical significance is identified:

  • Our genetic counselors provide detailed explanation
  • Regular updates as research progresses
  • Recommendations for family studies when appropriate
  • Guidance on clinical management despite uncertainty

Test Pricing and Details

Test Component Price (USD)
Discount Price $500
Regular Price $700
Test Name DRD2 Gene Myoclonic Dystonia NGS Genetic DNA Test
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card

Pre-Test Requirements

Before testing, we recommend:

  • Complete clinical history documentation
  • Genetic counseling session to create family pedigree chart
  • Discussion of testing implications with healthcare provider
  • Informed consent process completion

Nationwide Testing Availability

We have diagnostic centers across the United States, serving patients in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Jacksonville, Fort Worth, Columbus, San Francisco, and many more locations.

Convenient Testing Process

Our streamlined testing process ensures:

  • Easy sample collection at local facilities
  • Secure sample transportation and processing
  • Expert genetic analysis by certified laboratory professionals
  • Comprehensive result reporting with genetic counseling support

Take Control of Your Neurological Health

Don’t let uncertainty about your movement disorder symptoms continue. The DRD2 Gene Myoclonic Dystonia NGS Genetic DNA Test provides the answers you need for proper diagnosis and treatment planning. Our team of neurological genetics specialists is ready to help you understand your genetic profile and develop an effective management strategy.

Book Your Test Today

Take the first step toward definitive diagnosis and personalized treatment. Contact our genetic counseling team to schedule your test or discuss your testing options.

Call or WhatsApp: +1(267) 388-9828

Our dedicated patient coordinators are available to answer your questions, explain the testing process, and help you schedule your appointment at a convenient location near you. Early diagnosis leads to better outcomes – don’t delay in seeking the answers you deserve.